PrEP

Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
Clinical Trials Arena
Sun, 12/1/24 - 11:46 am
Gilead Sciences
clinical trials
lenacapavir
HIV
PrEP
With Gilead coming fast, GSK bolsters case for long-acting HIV PrEP drug Apretude
Fierce Pharma
Thu, 10/17/24 - 09:23 am
GSK
Gilead Sciences
PrEP
HIV
Apretude
GSK’s ViiV to expand supply of HIV drug in Africa
BioPharma Dive
Mon, 10/7/24 - 09:47 pm
GSK
ViiV Healthcare
HUV
PrEP
Africa
US government appeals Gilead's trial win in Truvada, Descovy patent fight
Fierce Pharma
Tue, 07/9/24 - 12:01 pm
Gilead Sciences
HIV
PrEP
Truvada
Descovy
patents
Gilead plans European trial of twice-yearly HIV PrEP drug
Pharmaphorum
Wed, 10/18/23 - 10:08 am
Gilead Sciences
clinical trials
HIV
PrEP
Sunlenca
Europe
ViiV Healthcare receives European Commission approval for Apretude
Pharmaceutical Business Review
Wed, 09/20/23 - 08:33 am
ViiV Healthcare
Europe
Apretude
HIV
AIDS
PrEP
Medicare proposes coverage for PrEP without patient cost sharing
Fierce Healthcare
Fri, 07/14/23 - 09:58 am
Medicare
CMS
HIV
PrEP
Gilead, US government set for courtroom showdown over PrEP drug patents
Fierce Pharma
Tue, 05/2/23 - 11:45 am
Gilead Sciences
legal
patents
Truvada
Descovey
PrEP
Federal claims court rules in favor of Gilead in CDC Truvada patent case
Endpoints
Thu, 12/1/22 - 07:08 pm
Gilead Sciences
Truvada
PrEP
HIV
CDC
patents
Judge invalidates parts of the ACA that mandate health coverage of many preventive services and drugs
Stat
Wed, 09/7/22 - 11:38 pm
ACA
legal HIV
PrEP
insurance
GSK, still early in US launch, licenses long-acting HIV PrEP drug Apretude to patent pool for poorer nations
Fierce Pharma
Thu, 07/28/22 - 12:33 pm
GSK
HIV
PrEP
Apretude
Medicines Patent Pool
'Who wants to make money?' Court documents outline wild fraud scheme targeting Gilead HIV meds
Fierce Pharma
Fri, 05/6/22 - 10:46 am
Gilead Sciences
legal
fraud
HIV
PrEP
Gilead presses HIV drug fraud in court, wins freeze of 'kingpin' assets
Fierce Pharma
Wed, 04/20/22 - 10:56 am
Gilead Sciences
fraud
HIV
PrEP
Truvada
Descovy
FDA clears first long-acting HIV-prevention injectable, giving ViiV claim to historic OK
Endpoints
Tue, 12/21/21 - 10:24 am
FDA
HIV
PrEP
Apretude
GSK
ViiV Healthcare
Digital pill tracks HIV PrEP adherence with 98% accuracy
Pharmaforum
Thu, 12/9/21 - 10:38 am
digital pills
HIV
PrEP
Gilead Sciences
GSK's ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms
Fierce Pharma
Tue, 11/30/21 - 11:24 pm
ViiV Healthcare
GSK
HIV
PrEP
cabotegravir
Mid-Study Peek at Merck's Once-A-Month HIV Preventative Shows Promise
BioSpace
Tue, 07/20/21 - 11:45 pm
Merck
HIV
clinical trials
islatravir
PrEP
Fierce Pharma's top 2020 marketing stories pack pandemic punch to digital, reputation and drug launches
Fierce Pharma
Wed, 12/23/20 - 10:51 am
pharma marketing
drug pricing
COVID-19
pandemic
remdesivir
Gilead Sciences
HIV
PrEP
Pfizer
GSK and ViiV score breakthrough therapy designation in HIV prevention, as Truvada showdown draws nearer
Endpoints
Tue, 11/17/20 - 11:12 pm
GSK
ViiV
FDA
cabotegravir
HIV
PrEP
GSK reports its long-acting HIV PrEP tops Gilead's Truvada — again
Endpoints
Mon, 11/9/20 - 11:56 am
GSK
ViiV
cabotegravir
HIV
PrEP
FDA

Pages